首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
DNA MOLECULES WHICH CODE FOR A PLASTID 2-OXOGLUTARATE/MALATE TRANSLOCATOR
摘要
申请公布号
HU9603441(D0)
申请公布日期
1997.02.28
申请号
HU19960003441
申请日期
1995.06.14
申请人
INSTITUT FUER GENBIOLOGISCHE FORSCHUNG BERLIN GMBH.
发明人
FISCHER,KARSTEN;FLUEGGE,ULF-INGO;WEBER,ANDREAS
分类号
A01H5/00;C07H21/04;C07K14/415;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/29;C12N15/81;C12N15/82;C12P21/02;C12Q1/68;C12R1/19;C12R1/645
主分类号
A01H5/00
代理机构
代理人
主权项
地址
您可能感兴趣的专利
MOBILE PHONE CASING
MOBILE WIRELESS COMMUNICATIONS DEVICE INCLUDING A SELF-CONTAINED RECHARGEABLE BATTERY PACK WITH FILTER AND RELATED METHODS
Position Determination Using Round-Trip Delay and Angle-of-Arrival
PROTECTIVE DEVICE FOR AN ELECTRICAL CONNECTION OF AN ON-BOARD DEVICE OF A BICYCLE
COMPOSITE MATERIAL, METHOD FOR PRODUCING THE SAME, AND APPARATUS FOR PRODUCING THE SAME
METHOD FOR PROCESSING SUBSTRATE AND METHOD FOR FABRICATING APPARATUS
HETEROSTRUCTURE CONTAINING IC AND LED AND METHOD FOR FABRICATING THE SAME
SYSTEM AND METHOD FOR CHEMICAL AND/OR BIOLOGICAL DETECTION
DinQ-sRNA TYPE I TOXIN-ANTITOXIN SYSTEM FOR PLASMID MAINTENANCE
Dendrimer-Based Excipients for the Attenuation of Protein Aggregation
METHODS AND COMPOSITIONS FOR DEGRADING PECTIN
PROCESS FOR SEPARATION OF RENEWABLE MATERIALS FROM M ICROORGANISMS
RESIST UNDERLAYER FILM FORMING COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING THE SAME
POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION BATTERY, METHOD OF PRODUCING THE SAME, ELECTRODE FOR LITHIUM ION BATTERY, AND LITHIUM ION BATTERY
SECONDARY BATTERY OF NOVEL STRUCTURE
SEPARATOR AND METHOD FOR MANUFACTURING SEPARATOR
SLURRY, PRODUCTION METHOD FOR SOLID ELECTROLYTE LAYER, PRODUCTION METHOD FOR ELECTRODE ACTIVE MATERIAL LAYER, AND PRODUCTION METHOD FOR ALL-SOLID-STATE BATTERY
COMPOSITION COMPRISING DIAMINE OXIDASE FOR USE IN THE TREATMENT OR PREVENTION OF FIBROMYALGIA OR CHRONIC FATIGUE SYNDROME
Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis
IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS
